Bristol-Myers Squibb Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
175 result(s) found, displaying 71 to 80
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: Ipilimumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OPDIVO nivolumab 100 mg in 10 mL (10 mg/mL) concentrated solution for IV infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OPDIVO nivolumab 40 mg in 4 mL (10 mg/mL) concentrated solution for IV infusion vial.
-
Prescription medicine registrationActive ingredients: nivolumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REVLIMID lenalidomide 2.5mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REVLIMID lenalidomide 7.5mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REVLIMID lenalidomide 20mg capsule blister pack.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Nivolumab